Events

Drug Safety 2018

11 - 12 June 2018, London, UK.
SMi Group are delighted to announce their 5th Drug Safety conference. For drugs anywhere, it's the safety in patients which is a huge issue, constantly under surveillance, irrespective of where the drug is in its pipeline.

Controlled Release Delivery Conference 2018

21 - 22 March, London, UK.
An industry-leading show, SMi have been running this conference for 15 years - a testament of how vital this particular focus is to the biotech and pharma sector. As physicians and scientists continue to find strategies to assist in simplifying treatment schedules for patients, a pharma focus continues to move towards innovative controlled release technologies to improve drug transport to target.

Superbugs & Superdrugs Conference 2018

19 - 20 March 2018, London, UK.
SMi's Superbugs & Superdrugs conference this March will focus on the strategies pharmaceutical companies use to assist the development of new therapeutics & drugs, how to obtain funding for new projects and address why there is a current lack of incentives for researchers working in antimicrobial resistance research and development.

Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference 2018

21 - 22 May 2018, London, UK.
SMi is delighted to announce its 2nd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London. The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs.

Injectable Drug Delivery conference 2018

16 - 17 May 2018, London, UK.
The SMi Group are thrilled to present the launch of Injectable Drug Delivery Conference 2018. The event is taking place in central London on 16th and 17th May 2018, with two pre-conference workshops occurring on 15th May 2018.

Antibodies & Antibody Drug Conjugates

9 - 10 April 2018, London, UK.
SMi is proud to present their 6th annual Antibodies and Antibody Drug Conjugates conference, being held at the Copthorne Tara Hotel, London, UK. With an every-growing industry, the market is expected to reach USD 30 Billion by 2023. Antibodies and antibody drug conjugates (ADCs) have the potential to make a ground-breaking impact upon medicinal therapies, diagnostics and characterization of diseases.

SMi Group announces the 9th Annual RNA Therapeutics Conference

21 - 22 February 2018, London, UK.
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models,

Events

More Pharma News ...